RHEP · Regional Health Properties, Inc
Price & Indicators
Up next
Metrics snapshot
Useful current figures from the complete screener profile.
Quarterly results
* Q4 derived as the full year minus Q1 to Q3.
Equibles Rating
blended score · not investment adviceBlended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders NeutralIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Adjusted EBITDA from operations non-GAAP | $749K | Three Months Ended June 30, 2026 filing | — |
GAAP → non-GAAP reconciliationGAAP Net loss -$791K
+$757K Depreciation and amortization
+$567K Interest expense, net
+$73K Amortization of employee stock compensation
+$0K Merger and other one-time costs
+$0K Loss on lease termination
+$0K Gain on operations transfer
+$0K Tail insurance on legacy facilities
+$143K Other one-time costs
= Adjusted EBITDA from operations $749K
|
|||
| EBITDA non-GAAP | $533K | Three Months Ended June 30, 2026 filing | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
Medical Care Facilities — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
RHEP
this stock
Regional Health Properties, Inc
|
$4.08M | -18.8% | +189.9% | 0.9 | 0.2% |
|
HCA
HCA Healthcare, Inc.
|
$100.91B | -0.2% | +7.1% | 15.3 | 2.2% |
|
FSNUY
Fresenius SE & Co. KGaA
|
$28.52B | -11.7% | — | — | 0.0% |
|
THC
Tenet Healthcare Corp
|
$21.45B | +37.0% | +0.9% | 10.3 | 2.3% |
|
EHC
Encompass Health Corp
|
$12.01B | +14.6% | +10.5% | 19.8 | 3.5% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every section- % held
- 0.7%
- Net QoQ
- +6.9K sh
- Top holder
- VANGUARD GROUP INC
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| RHEP | +4.0% | +3.0% | -16.8% | +2.0% | -18.8% |
| SPY | -1.5% | -0.9% | +7.7% | +0.5% | +12.4% |
| vs SPY | +5.5% | +3.9% | -24.5% | +1.5% | -31.2% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.